PARIS, Sept. 3, 2024 /PRNewswire/ — European MedTech startup AZmed, recognized as a leading company in AI for medical imaging, today announced that its Rayvolve solution has received 510(k) clearance from the Food and Drug Administration (FDA) for detecting fractures on pediatric X-rays. This milestone comes two years after receiving FDA clearance for adult fracture detection, positioning Rayvolve as a top-performing solution for detecting fractures in adult and pediatric patients. The clearance was supported by an independent study conducted with SimonMed Imaging, one of the largest outpatient imaging providers in the U.S.

BELFAST, Northern Ireland, Sept. 3, 2024 /PRNewswire/ — B-Secur, a leader in advanced biosensing technology, proudly announces the FDA clearance and launch of HeartKey® Rhythm, a suite of electrocardiogram (ECG) algorithms and analytics designed to enhance clinical confidence, streamline industry efficiency, and improve outcomes for cardiac patients.

ENGLEWOOD, Colo., Sept. 3, 2024 /PRNewswire/ — Zynex Inc. (NASDAQ: ZYXI), a leading medical technology company specializing in non-invasive medical devices for pain management and rehabilitation, today announced FDA clearance of its new TensWave device

SUNNYVALE, Calif., Sept. 3, 2024 /PRNewswire/ — VELMENI announced today it received FDA 510(k) clearance for VELMENI for DENTISTS, an innovative AI that analyzes and annotates dental X-Rays

Embecta (Nasdaq:EMBC) today entered the insulin patch pump market with a major regulatory milestone.

Vitestro says it is the first company ever to achieve CE marking for an autonomous blood drawing device.

MIT engineers’ implantable ImPULS device could become an alternative to the electrodes now used to treat Parkinson’s and other diseases.

Women are offered the opportunity to benefit from Carevix at the Peterborough City Hospital – North West Anglia NHS Foundation Trust.